The safety of tulathromycin administration in goats.
Washburn
K E
KE
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA. kwashburn@cvm.tamu.edu
Bissett
W
W
Fajt
V
V
Clubb
F
F
Fosgate
G T
GT
Libal
M
M
Smyre
K E
KE
Cass
K L
KL
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D004187:Disaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D005243:Feces / Q000737:chemistry; D015511:Goat Diseases / Q000188:drug therapy; D006041:Goats / Q000378:metabolism*; D006339:Heart Rate; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D007279:Injections, Subcutaneous; D008297:Male; D012766:Pasteurellosis, Pneumonic / Q000188:drug therapy; D018942:Macrolides
D000900:Anti-Bacterial Agents; D004187:Disaccharides; D006571:Heterocyclic Compounds; C485204:tulathromycin; D018942:Macrolides